Predictive Oncology Corp (POAI) - סך כל נכסי החברה

Predictive Oncology develops AI solutions for pharmaceutical corporations, leveraging its own biobank to accelerate the discovery of anti-tumor agents. The price trend of total assets, which currently stands at 5.35, links the technology stack with a team of leading oncologists attracted by academic freedom. However, a chronic lack of profitability due to the slow adoption of software within the industry creates certain financial risks.

This indicator reflects the aggregate volume of business resources and liabilities, calculated inversely via return on assets (ROA) to identify hidden risks of balance sheet inflation. The trend in consolidated assets demonstrates how effectively Predictive Oncology (POAI) capitalizes on its precision medicine AI ecosystem and tumor cell databases to scale its oncology intelligence center.